Tevogen details its artificial intelligence initiative, tevogen.ai; proprietary ai-powered immunotherapy with microsoft and databricks partnerships

Warren, n.j., may 30, 2025 (globe newswire) -- tevogen (“tevogen bio holdings inc.” or “company”) (nasdaq: tvgn), today provided stockholders with a detailed overview of its artificial intelligence initiative, tevogen.ai™.

MSFT Ratings Summary

MSFT Quant Ranking